FGF21 and obesity disorder: Mice that were deficient in KLB specifically from adipocytes were refractory to the effects of recombinant FGF21 to increase subcutaneous fat mass (3), suggesting that direct FGF21 signaling to adipocytes is required for subcutaneous fat expansion in obesity.